Skip to main content
Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
7.49
-0.03 (-0.40%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Telix Pharmaceuticals Revenue

In the year 2025, Telix Pharmaceuticals had annual revenue of $803.79M with 55.61% growth. Telix Pharmaceuticals had revenue of $413.44M in the half year ending December 31, 2025, with 115.29% growth.

Revenue (ttm)
$803.79M
Revenue Growth
+55.61%
P/S Ratio
3.02
Revenue / Employee
$678,880
Employees
1,184
Market Cap
2.42B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025803.79M287.24M55.61%
Dec 31, 2024516.55M183.57M55.13%
Jan 1, 2024332.98M224.17M206.01%
Dec 31, 2022108.81M103.29M1,870.12%
Dec 31, 20215.52M1.50M37.33%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Apellis Pharmaceuticals 1.00B
Travere Therapeutics 490.73M
Arcus Biosciences 247.00M
Beam Therapeutics 139.74M
Tango Therapeutics 62.38M
Wave Life Sciences 42.73M
Immunome 6.94M
Dianthus Therapeutics 3.08M
Revenue Rankings

TLX News

More News